Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 077180
Company: PERRIGO ISRAEL
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
MOMETASONE FUROATE MOMETASONE FUROATE 0.1% LOTION;TOPICAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/06/2005 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
10/08/2019 SUPPL-9 Labeling-Package Insert

Label is not available on this site.

07/27/2015 SUPPL-4 Labeling-Package Insert

Label is not available on this site.

MOMETASONE FUROATE

LOTION;TOPICAL; 0.1%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ELOCON MOMETASONE FUROATE 0.1% LOTION;TOPICAL Prescription Yes AB 019796 MERCK SHARP DOHME
MOMETASONE FUROATE MOMETASONE FUROATE 0.1% LOTION;TOPICAL Prescription No AB 077678 COSETTE
MOMETASONE FUROATE MOMETASONE FUROATE 0.1% LOTION;TOPICAL Prescription No AB 075919 FOUGERA PHARMS
MOMETASONE FUROATE MOMETASONE FUROATE 0.1% LOTION;TOPICAL Prescription No AB 090506 GLENMARK GENERICS
MOMETASONE FUROATE MOMETASONE FUROATE 0.1% LOTION;TOPICAL Prescription No AB 077180 PERRIGO ISRAEL
MOMETASONE FUROATE MOMETASONE FUROATE 0.1% LOTION;TOPICAL Prescription No AB 076788 TARO

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English